Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 8 filers reported holding Novozymes A/S in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $252 | -99.9% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $300,000 | 0.0% | 5,000 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $300,000 | -12.5% | 5,000 | 0.0% | 0.02% | +5.3% |
| Q1 2022 | $343,000 | -17.5% | 5,000 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $416,000 | +21.6% | 5,000 | 0.0% | 0.02% | +9.5% |
| Q3 2021 | $342,000 | -9.3% | 5,000 | 0.0% | 0.02% | -12.5% |
| Q2 2021 | $377,000 | +17.4% | 5,000 | 0.0% | 0.02% | +9.1% |
| Q1 2021 | $321,000 | +12.6% | 5,000 | 0.0% | 0.02% | +10.0% |
| Q4 2020 | $285,000 | -9.5% | 5,000 | 0.0% | 0.02% | -23.1% |
| Q3 2020 | $315,000 | +9.0% | 5,000 | 0.0% | 0.03% | +4.0% |
| Q2 2020 | $289,000 | +27.3% | 5,000 | 0.0% | 0.02% | +13.6% |
| Q1 2020 | $227,000 | -7.0% | 5,000 | 0.0% | 0.02% | +10.0% |
| Q4 2019 | $244,000 | +16.2% | 5,000 | 0.0% | 0.02% | -13.0% |
| Q3 2019 | $210,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lenox Wealth Management, Inc. | 62,488 | $2,907,000 | 0.87% |
| ZEVIN ASSET MANAGEMENT LLC | 34,899 | $1,624,000 | 0.52% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 5,090 | $238,000 | 0.33% |
| BOSTON FINANCIAL MANGEMENT LLC | 108,846 | $5,065,000 | 0.29% |
| Moloney Securities Asset Management, LLC | 15,263 | $713,000 | 0.24% |
| Boston Common Asset Management, LLC | 24,577 | $1,148,000 | 0.14% |
| Hemenway Trust Co LLC | 12,125 | $564,000 | 0.09% |
| Renaissance Investment Group LLC | 5,000 | $234,000 | 0.09% |
| QUADRANT CAPITAL GROUP LLC | 5,748 | $263,000 | 0.04% |
| Douglass Winthrop Advisors, LLC | 6,902 | $321,000 | 0.01% |